<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2">As filed with the Securities and
Exchange Commission on May&nbsp;23, 2003
</FONT>
<P align="right"><FONT size="2"><B>Registration No.&nbsp;333-</B>
</FONT>
<p>
<HR size="1" noshade>




<div align="center"><FONT size="2">SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549
</FONT></div>
<p>
<hr noshade size="1" width="5%">
<P align="center"><FONT size="2">FORM S-8
</FONT>
<P align="center"><FONT size="2">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
</FONT>
<P>
<div align="center"><FONT size="2"><B>Martek Biosciences Corporation</B><hr noshade size="1" width="45%">
(Exact name of registrant as specified in its charter)
</FONT></div>
<P>
<div align="center"><FONT size="2"><B>Delaware</B><hr noshade size="1" width="55%">
(State or other jurisdiction of incorporation or organization)
</FONT></div>
<P>
<div align="center"><FONT size="2"><B>52-1399362</B><hr noshade size="1" width="30%">
(I.R.S. employer identification no.)
</FONT></div>
<P>
<div align="center"><FONT size="2"><B>6480 Dobbin Road, Columbia, Maryland 21045</B><hr noshade size="1" width="65%">
(Address of principal executive offices) (Zip code)
</FONT></div>
<P align="center"><FONT size="2"><u><B>Martek Biosciences Corporation 2002 Stock Incentive Plan</B></u>
</FONT>
<P>
<div align="center"><FONT size="2"><B>Henry Linsert, Jr.<BR>
Chief Executive Officer<BR>
Martek Biosciences Corporation<BR>
6480 Dobbin Road<BR>
Columbia, Maryland 21045</B><hr noshade size="1" width="30%">
(Name and address of agent for service)
</FONT></div>
<P>
<div align="center"><FONT size="2"><B>(410)&nbsp;740-0081</B><hr noshade size="1" width="55%">
(Telephone number, including area code, of agent for service)
</FONT></div>
<P align="center"><FONT size="2">Copy to:<BR>
<B>Michael J. Silver<BR>
Hogan &#038; Hartson L.L.P.<BR>
111 South Calvert Street<BR>
Baltimore, Maryland 21202<BR>
(410)&nbsp;659-2741</B>
</FONT>
<P align="center"><FONT size="2">CALCULATION OF REGISTRATION FEE
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="33%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="17" align="left"><DIV style="margin-left:10px; text-indent:-10px"><HR size="4" noshade></DIV></TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed maximum</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B></B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Title of securities</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount to be</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>maximum offering</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>aggregate offering</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount of</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>to be registered</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>registered(1)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>price per share(1)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>price(1)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>registration fee(1)</B></FONT></TD>
</TR>
<TR>
    <TD colspan="17" align="left"><DIV style="margin-left:10px; text-indent:-10px"><HR size="1" noshade></DIV></TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock, par
value $.10 per
share (2)</FONT></DIV></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right"><FONT size="2">300,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right"><FONT size="2">$</FONT></TD>
    <TD align="right"><FONT size="2">34.35</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right"><FONT size="2">$</FONT></TD>
    <TD align="right"><FONT size="2">10,305,000</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right"><FONT size="2">$</FONT></TD>
    <TD align="right"><FONT size="2">833.67</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR>
    <TD colspan="17" align="left"><DIV style="margin-left:10px; text-indent:-10px"><HR size="4" noshade></DIV></TD>
</TR>
</TABLE>
</CENTER>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Pursuant to Rules&nbsp;457(c) and 457(h)(1), the proposed maximum offering
price per share, proposed maximum aggregate offering price and the
amount of the registration fee are based on the average of the high and
low price of $34.35 per share of Martek Biosciences Corporation common
stock on May&nbsp;20, 2003 as reported on the Nasdaq National Market.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Includes Series&nbsp;A Preferred Share Purchase Rights attached thereto,
for which no separate fee is payable pursuant to Rule&nbsp;457(i).</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>




<P align="center"><FONT size="2"><B>Explanatory Note</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement on Form&nbsp;S-8 of Martek Biosciences Corporation
(&#147;<B>Martek</B>&#148;) is being filed to register 300,000 additional shares of common stock
authorized for issuance under Martek&#146;s 2002 Stock Incentive Plan, as amended
(the &#147;<B>2002 Plan</B>&#148;). Martek previously registered 1,682,000 shares of common
stock previously authorized for issuance under the 2002 Plan. The total number
of shares currently authorized for issuance under the 2002 Plan is 1,982,000.
See Registration Statement on Form&nbsp;S-8 (Registration No.&nbsp;333-85856) which was
filed with the SEC on April&nbsp;8, 2002. In accordance with Section&nbsp;E of the
General Instructions to Form&nbsp;S-8, the contents of Form&nbsp;S-8, Registration No.
333-85856, filed by Martek Biosciences Corporation with the SEC on April&nbsp;8,
2002, are incorporated herein by reference.
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="91%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="2">Exhibit</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="2"><u>Number</u></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="2"><u>Description</u></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">5.01</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Opinion of Hogan &#038; Hartson L.L.P. regarding the legality of the shares of
Common Stock being registered.*</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">10.01</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Amendment to the 2002 Stock Incentive Plan.*</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.01</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Ernst &#038; Young LLP.*</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.02</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Hogan &#038; Hartson L.L.P. (contained in Exhibit&nbsp;5.01).*</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">24</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Power of Attorney (contained on signature page).*</FONT></TD>
</TR>
</TABLE>
</CENTER>
<p>
<HR size="1" noshade>




<P><FONT size="2">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form&nbsp;S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the County of Howard, Maryland, on May&nbsp;23, 2003.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="60%">
<TR valign="bottom">
    <TD width="57%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="38%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="2" valign="top"><FONT size="2">Martek Biosciences Corporation</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD valign="top"><FONT size="2">By:</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
<u>/s/ Henry Linsert, Jr.</u><br>
Henry Linsert, Jr.<BR>
Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the date indicated.
</FONT>
<P><FONT size="2">We, the undersigned officers and directors of Martek Biosciences Corporation,
hereby severally and individually constitute and appoint Henry Linsert, Jr.,
Peter L. Buzy and George P. Barker, and each of them, the true and lawful
attorneys and agents of each of us to execute in the name, place and stead of
each of us (individually and in any capacity stated below) any and all
amendments to this Registration Statement on Form&nbsp;S-8, and all instruments
necessary or advisable in connection therewith and to file the same with the
Securities and Exchange Commission, each of said attorneys and agents to have
power to act with or without the other and to have full power and authority to
do and perform in the name and on behalf of each of the undersigned every act
whatsoever necessary or advisable to be done in the premises as fully and to
all intents and purposes as any of the undersigned might or could do in
person, and we hereby ratify and confirm our signatures as they may be signed
by our said attorneys and agents and each of them to any and all such
amendment and amendments.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="29%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="36%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Henry Linsert, Jr.<BR>
</FONT><HR size="1" noshade><FONT size="2">
Henry Linsert, Jr.<BR>
Chief Executive Officer and Director<BR>
(Principal Executive Officer)</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Peter L. Buzy<BR>
</FONT><HR size="1" noshade><FONT size="2">
Peter L. Buzy<BR>
(Chief Financial and Accounting Officer)</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Jules Blake<BR>
</FONT><HR size="1" noshade><FONT size="2">
Jules Blake<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Gordon S. Macklin<BR>
</FONT><HR size="1" noshade><FONT size="2">
Gordon S. Macklin</FONT></TD>
</TR>

</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="29%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="36%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Robert J. Flanagan<BR>
</FONT><HR size="1" noshade><FONT size="2">
Robert J. Flanagan<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Douglas J. MacMaster, Jr.<BR>
</FONT><HR size="1" noshade><FONT size="2">
Douglas J. MacMaster, Jr.<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ John H. Mahar<BR>
</FONT><HR size="1" noshade><FONT size="2">
John H. Mahar<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Sandra Panem<BR>
</FONT><HR size="1" noshade><FONT size="2">
Sandra Panem<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Richard J. Radmer<BR>
</FONT><HR size="1" noshade><FONT size="2">
Richard J. Radmer<BR>
Director</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Date: May 23, 2003</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
/s/ Eugene H. Rotberg<BR>
</FONT><HR size="1" noshade><FONT size="2">
Eugene H. Rotberg<BR>
Director</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "w86991sv8.htm", "description": "REGISTRATION STATEMENT, FORM S-8", "secsgml_size_bytes": 17356}]
{"company-data": {"conformed-name": "MARTEK BIOSCIENCES CORP", "cik": "0000892025", "assigned-sic": "2836", "irs-number": "521399362", "state-of-incorporation": "DE", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-105555", "film-number": "03718676"}, "business-address": {"street1": "6480 DOBBIN RD", "city": "COLUMBIA", "state": "MD", "zip": "21045", "phone": "4107400081"}, "mail-address": {"street1": "6480 DOBBIN RD", "city": "COLUMBIA", "state": "MD", "zip": "21045"}}
sv8
As filed with the Securities and
Exchange Commission on May 23, 2003
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Martek Biosciences Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
52-1399362
(I.R.S. employer identification no.)
6480 Dobbin Road, Columbia, Maryland 21045
(Address of principal executive offices) (Zip code)
Martek Biosciences Corporation 2002 Stock Incentive Plan
Henry Linsert, Jr.
Chief Executive Officer
Martek Biosciences Corporation
6480 Dobbin Road
Columbia, Maryland 21045
(Name and address of agent for service)
(410) 740-0081
(Telephone number, including area code, of agent for service)
Copy to:
Michael J. Silver
Hogan & Hartson L.L.P.
111 South Calvert Street
Baltimore, Maryland 21202
(410) 659-2741
CALCULATION OF REGISTRATION FEE
Proposed
Proposed maximum
Title of securities
Amount to be
maximum offering
aggregate offering
Amount of
to be registered
registered(1)
price per share(1)
price(1)
registration fee(1)
Common Stock, par
value $.10 per
share (2)
300,000
$
34.35
$
10,305,000
$
833.67
(1)
Pursuant to Rules 457(c) and 457(h)(1), the proposed maximum offering
price per share, proposed maximum aggregate offering price and the
amount of the registration fee are based on the average of the high and
low price of $34.35 per share of Martek Biosciences Corporation common
stock on May 20, 2003 as reported on the Nasdaq National Market.
(2)
Includes Series A Preferred Share Purchase Rights attached thereto,
for which no separate fee is payable pursuant to Rule 457(i).
Explanatory Note
This Registration Statement on Form S-8 of Martek Biosciences Corporation
("
Martek
") is being filed to register 300,000 additional shares of common stock
authorized for issuance under Martek's 2002 Stock Incentive Plan, as amended
(the "
2002 Plan
"). Martek previously registered 1,682,000 shares of common
stock previously authorized for issuance under the 2002 Plan. The total number
of shares currently authorized for issuance under the 2002 Plan is 1,982,000.
See Registration Statement on Form S-8 (Registration No. 333-85856) which was
filed with the SEC on April 8, 2002. In accordance with Section E of the
General Instructions to Form S-8, the contents of Form S-8, Registration No.
333-85856, filed by Martek Biosciences Corporation with the SEC on April 8,
2002, are incorporated herein by reference.
EXHIBIT INDEX
Exhibit
Number
Description
5.01
Opinion of Hogan & Hartson L.L.P. regarding the legality of the shares of
Common Stock being registered.*
10.01
Amendment to the 2002 Stock Incentive Plan.*
23.01
Consent of Ernst & Young LLP.*
23.02
Consent of Hogan & Hartson L.L.P. (contained in Exhibit 5.01).*
24
Power of Attorney (contained on signature page).*
*     Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the County of Howard, Maryland, on May 23, 2003.
Martek Biosciences Corporation
By:
/s/ Henry Linsert, Jr.
Henry Linsert, Jr.
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the date indicated.
We, the undersigned officers and directors of Martek Biosciences Corporation,
hereby severally and individually constitute and appoint Henry Linsert, Jr.,
Peter L. Buzy and George P. Barker, and each of them, the true and lawful
attorneys and agents of each of us to execute in the name, place and stead of
each of us (individually and in any capacity stated below) any and all
amendments to this Registration Statement on Form S-8, and all instruments
necessary or advisable in connection therewith and to file the same with the
Securities and Exchange Commission, each of said attorneys and agents to have
power to act with or without the other and to have full power and authority to
do and perform in the name and on behalf of each of the undersigned every act
whatsoever necessary or advisable to be done in the premises as fully and to
all intents and purposes as any of the undersigned might or could do in
person, and we hereby ratify and confirm our signatures as they may be signed
by our said attorneys and agents and each of them to any and all such
amendment and amendments.
Date: May 23, 2003
/s/ Henry Linsert, Jr.
Henry Linsert, Jr.
Chief Executive Officer and Director
(Principal Executive Officer)
Date: May 23, 2003
/s/ Peter L. Buzy
Peter L. Buzy
(Chief Financial and Accounting Officer)
Date: May 23, 2003
/s/ Jules Blake
Jules Blake
Director
Date: May 23, 2003
/s/ Gordon S. Macklin
Gordon S. Macklin
Date: May 23, 2003
/s/ Robert J. Flanagan
Robert J. Flanagan
Director
Date: May 23, 2003
/s/ Douglas J. MacMaster, Jr.
Douglas J. MacMaster, Jr.
Director
Date: May 23, 2003
/s/ John H. Mahar
John H. Mahar
Director
Date: May 23, 2003
/s/ Sandra Panem
Sandra Panem
Director
Date: May 23, 2003
/s/ Richard J. Radmer
Richard J. Radmer
Director
Date: May 23, 2003
/s/ Eugene H. Rotberg
Eugene H. Rotberg
Director